
Cytokinetics Investor Relations Material
Latest events

AGM 2025
Cytokinetics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Cytokinetics Inc
Access all reports
Cytokinetics Inc is a biopharmaceutical company focused on developing small-molecule therapies aimed at muscle function. The company targets diseases associated with impaired cardiac and skeletal muscle performance, including heart failure and neuromuscular disorders. Its operations include clinical development and research. The company is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.
Key slides for Cytokinetics Inc


Investor & Analyst Day 2024
Cytokinetics Inc


Corporate Presentation
Cytokinetics Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
CYTK
Country
🇺🇸 United States